To view this email as a web page, click here.

ONCOLOGY: Practical, Peer-Reviewed Perspectives

Volume 33, Number 7

Click here to view the full table of contents.

Click here for the Digital Edition

ARTICLE

Evolution of Lung Cancer Screening Management

Claudia I. Henschke, PhD, MD, David F. Yankelevitz MD, Anthony P. Reeves PhD, Rowena Yip, MPH
Throughout the last half of the 20th century, despite enormous research efforts, lung cancer remained the most feared as well as lethal cancer across the world. Efforts to update screening management are attempting to change that.

INSIGHTS FROM AN ONCOLOGY PHARMACIST

Management of Midostaurin-CYP3A4 Drug-Drug Interactions in Patients With Acute Myeloid Leukemia

Danielle Schlafer, PharmD, BCOP
This article summarizes available data for the use of CYP3A4 inhibitors with midostaurin for acute myeloid leukemia.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.